Randy Guerra, MD

Global Medical Lead
Takeda Development Center Americas, Inc., Cambridge, MA, USA
Cambridge, Massachusetts, United States

Randy Guerra, MD - Global Medical Lead - Rare Hematology - Takeda. Randy Guerra is the Global Medical Director for Rare Hematology at Takeda in charge of the Hemophilia A portfolio. He's based in Cambridge, Massachussetts and has been with the company for 7 years in the Hemophilia A space.

Presentation(s):

• PB0632 - Quality of life outcomes following treatment with octocog alfa in patients with hemophilia A: 9-year interim read-out of the real-world AHEAD international study

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB0636 - Clinical outcomes following treatment with octocog alfa in patients with severe hemophilia A and pre-existing target joints: 9-year interim read-out of the real-world AHEAD international study

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB0666 - Clinical outcomes following treatment with octocog alfa in patients with hemophilia A: 9-year interim read-out of the real-world AHEAD international study

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB1268 - Clinical Outcomes with Octocog Alfa in Patients with Hemophilia A in China: 1-year of Follow-up of the AHEAD International Study

  Tuesday, June 27, 2023
  18:30 – 19:30 ET